abstract |
The present invention relates to an intranasal composition comprising 5HT 1B/1D receptor agonists for treatment of cluster headache, migraine, pain, chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. More particularly, the invention relates to an intranasal composition comprising at least one efflux modulator along with other pharmaceutically acceptable excipients. |